## BACKGROUND. Recommendations for the proper treatment of women diagnosed with an equivocal atypical squamous cells of undetermined significance (ASCUS) Papanicolaou (Pap) smear are controversial. To the authors' knowledge, there currently are no methods available that can identify accurately ASC
Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance
โ Scribed by Lydia Pleotis Howell; Robin L. Davis
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 633 KB
- Volume
- 14
- Category
- Article
- ISSN
- 8755-1039
No coin nor oath required. For personal study only.
โฆ Synopsis
In the first year since the institution of the Bethesda system at UCDMC, 549/7,388 (7.43%) Papanicolaou (Pap) smears were diagnosed as having an epithelial abnormality. One hundred ninety-three of the 549 (35. I %) of the abnormal smears received an ASCUS diagnosis, representing 2.61 % of the total volume. Follow-up was obtained on 124/193 (64.2%) and consisted of colposcopy with biopsy in 38.3%. one repeat Pap smear in 51.2%, and two or more repeat Pap smears in 10.5%. Follow-up revealed a squamous intraepithelial lesion (SIL) in 29. I %, ASCUS in 12.9%, and no evidence of an epithelial lesion in 58.0%. Review of the original ASCUS Pap smear from the group with no epithelial lesion on follow-up showed increased inflammation plus metaplasia and/or reactive changes in 69.5% and ASCUS in 19.5%.
This study demonstrates that a signi5cant percentage of ASCUS Pap smears represent SIL. However, many Pap smears with reactive, inflammatory changes are misclassified as ASCUS and would be best diagnosed under "Reactive/Reparative Changes" in the Bethesda system. Careful attention to criteria for ASCUS and inflammatory and reactive atypia is recommended to avoid misclassijfcation and to make this category more meaningf u l to the clinician.
๐ SIMILAR VOLUMES
## BACKGROUND. The current study reports on the significance of cervical smears identified as atypical squamous cells of undetermined significance (ASCUS) in the largest Asian screening population to date.
The Bethesda System recommends that the diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) be qualified when possible to indicate whether a reactive process, or a squamous intraepithelial lesion (SIL), is favored. In order to evaluate the utility of this recommendation, 308
## Background: There is an increasing number of articles regarding the long term follow-up of papanicolaou (pap) smears with the diagnosis of atypical squamous cells of undetermined significance (ascus). much controversy exists regarding the management of patients with this diagnosis. in a prior st